Feb 2 (Reuters) - Amgen Inc:
* AMGEN - ANNOUNCED FDA APPROVED TEZSPIRE FOR SELF-ADMINISTRATION IN PRE-FILLED, SINGLE-USE PEN FOR PATIENTS AGED 12 YEARS & OLDER WITH SEVERE ASTHMA
* AMGEN INC - FDA HAS APPROVED TEZSPIRE FOR SELF-ADMINISTRATION IN U.S. WITH A NEW PRE-FILLED PEN Source text for Eikon: Further company coverage: